- Home
- SST vs VRCA Comparison
SST vs VRCA Comparison
Compare SST & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SST | VRCA |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | United States | United States |
| Employees | 250 | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9M | 87.5M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | SST | VRCA |
|---|---|---|
| Price | $3.38 | $4.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $10.00 | ★ $17.00 |
| AVG Volume (30 Days) | 34.4K | ★ 120.8K |
| Earning Date | 03-11-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $35,577,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $92.12 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 370.22 |
| 52 Week Low | $0.29 | $0.39 |
| 52 Week High | $11.30 | $9.82 |
Technical Indicators
Market Signals| Indicator | SST | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 66.21 | 31.13 |
| Support Level | $3.09 | $3.96 |
| Resistance Level | $4.61 | $4.87 |
| Average True Range (ATR) | 0.53 | 0.59 |
| MACD | 0.12 | -0.13 |
| Stochastic Oscillator | 70.59 | 5.40 |
Price Performance
Historical ComparisonAbout SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It operate several flagship brands across multiple consumer verticals, including shopping, travel and search, and a customer acquisition and marketing platform powered by Artificial Intelligence and machine learning. The company's segment includes Marketing and Products. It generates maximum revenue from the Marketing segment. Geographically, it operates in United States and Other countries.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.